The following two articles have been retracted by the authors for uncertainty in the integrity of some of the published data:
1: Motlekar NA, Fasano A, Wachtel MS, Youan BB. 2006.
Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
J Drug Target 14(5):321–329.
2: Motlekar NA, Srivenugopal KS, Wachtel MS, Youan BB. 2005.
Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.
J Drug Target 13(10):573–583.